Your browser doesn't support javascript.
loading
PD-L1+ neutrophils contribute to injury-induced infection susceptibility.
Thanabalasuriar, Ajitha; Chiang, Abby J; Morehouse, Christopher; Camara, Margarita; Hawkins, Shonda; Keller, Ashley E; Koksal, Adem C; Caceres, Carolina S; Berlin, Aaron A; Holoweckyj, Nicholas; Takahashi, Virginia N; Cheng, Lily; de Los Reyes, Melissa; Pelletier, Mark; Patera, Andriani C; Sellman, Bret; Hess, Sonja; Marelli, Marcello; Boo, Chelsea C; Cohen, Taylor S; DiGiandomenico, Antonio.
Affiliation
  • Thanabalasuriar A; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Chiang AJ; McGill University, Department of Pharmacology and Therapeutics, Faculty of Medicine, Montreal, QC Canada.
  • Morehouse C; Dynamic Omics, Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Camara M; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Hawkins S; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Keller AE; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, AstraZeneca, Gaithersburg, MD, USA.
  • Koksal AC; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Caceres CS; Dynamic Omics, Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Berlin AA; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Holoweckyj N; Respiratory and Immunology, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Takahashi VN; Research and Early Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Cheng L; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • de Los Reyes M; Research and Early Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Pelletier M; Research and Early Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Patera AC; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Sellman B; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Hess S; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Marelli M; Dynamic Omics, Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Boo CC; Dynamic Omics, Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Cohen TS; Dynamic Omics, Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Gaithersburg, MD, USA.
  • DiGiandomenico A; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Sci Adv ; 7(10)2021 03.
Article in En | MEDLINE | ID: mdl-33674305
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Journal: Sci Adv Year: 2021 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Journal: Sci Adv Year: 2021 Type: Article Affiliation country: United States